Japan Residential Substance Abuse and Mental Health Facilities Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Residential Substance Abuse and Mental Health Facilities is expanding as a result of rising prevalence of mental health disorders, innovation in healthcare, and improvements in healthcare infrastructure. This demand is growing the market for Residential Substance Abuse and Mental Health Facilities as more people avail these services. Some of the key players in the global Residential Substance Abuse and Mental Health Facilities Market Kaiser Permanente, Universal Health Services, Ohio Department of Mental Health and Addiction Services, NHS England, Acadia Healthcare Company, CareTech Holdings PLC, Pyramid Healthcare, The MENTOR Network, Behavioral Health Network, Inc., and Strategic Behavioral Health.
Japan Retirement Communities Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Retirement Communities is expanding as a result of growing baby boomers and changing social norms of the family. This is fueling the demand for Retirement Communities market to provide support to these people. Some of the key players in the global Retirement Communities Market include Brookdale Senior Living Inc., Sunrise Senior Living, Atria Senior Living Group, Life Care Centers of America, Erickson Living, Holiday Retirement, Senior Lifestyle Corp., Affinity Living Group, HC-One Ltd., and Covenant Retire Communities Inc.
Japan Revenue Cycle Management Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The Revenue Cycle Management market is expanding due to huge growth opportunities created by expanding SMEs across the regions and increasing demand for workflow optimization in both developed and developing nations. This demand is fueling the development of better software systems and procedures for Revenue Cycle Management. Some of the key players in the global Revenue Cycle Management Market include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., McKesson Corporation, GE Healthcare, Quest Diagnostics, NextGen Healthcare, Inc., eClinicalWorks, and R1 RCM Inc.
Japan Revenue Cycle Management Software Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Revenue Cycle Management Software is expanding as a result of huge growth opportunities created by expanding SMEs across the regions and increasing demand for workflow optimization in both developed and developing nations. This demand is fueling the development of better software systems and procedures for Revenue Cycle Management. Some of the key players in the global Revenue Cycle Management Software Market include Cerner Corporation, Epic Systems Corporation, McKesson Corporation, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., eClinicalWorks LLC, GE Healthcare, NextGen Healthcare, Inc., Quest Diagnostics Incorporated, and Siemens Healthineers AG.
Japan Sepsis Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Sepsis diagnostics is expanding as a result of the growing burden of infectious diseases and government initiatives and funding in both developed and developing nations. This demand is fueling the development of better diagnostic tools and methods for early diagnosis of sepsis. Some of the key players in the global Sepsis Diagnostics Market include bioM?rieux SA; Becton, Dickinson & Company; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Danaher Corp. (Beckman Coulter, Inc.); Luminex Corp.; Bruker Corp.; Cepheid, Bruker Corporation, Immunexpress, Inc., and Koninklijke Philips N.V.
Japan Skilled Nursing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Skilled Nursing is expanding as a result of increasing geriatric population and increasing prevalence of chronic disease. Increasing demand for post-acute are is also fueling the need for specialized and skilled nursing in developing and developed countries. Some of the key players in the global Skilled Nursing Market include Genesis Healthcare Inc., Brookdale Senior Living Inc., Ensign Group Inc., Life Care Centers of America, Kindred Healthcare Inc., Extendicare Inc., Sunrise Senior Living, Atria Senior Living, SavaSeniorCare Administrative Services LLC., and Consulate Health Care.
Japan Soft Tissue Repair Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Soft Tissue Repair is expanding as a result of increasing sports-related injuries and a rising aging population. Increasing demand for non-invasive treatment and advancements in technology are fueling the soft tissue repair market. Some of the key players in the global soft tissue repair market are Smith & Nephew, Arthrex, Stryker Corporation, Baxter, Johnson & Johnson, Medtronic, LifeNet Health, Becton, Dickinson and Company, Integra Life Sciences Corporation, CryoLife, Boston Scientific Corporation, Zimmer Biomet, Baxter International, ACell, Tissue Regenix Group, and Aroa Biosurgery.
Japan Spinal Implants Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Spinal Implants is expanding as a result of the rising prevalence of Spinal disorders, injuries, and fractures and the rising demand for advanced medical technology. Spinal cord injuries (SCI) are most common during road accidents and all of these spinal disorders are fueling the development of better procedures and devices for the implantation procedure of the spine. Some of the key players in the global Spinal Implants Market include Medtronic, Zimmer Biomet, Alphatec Spine Inc., RTI Surgical, Stryker, Orthofix US LLC, NuVasive Inc., Globus Medical, Aesculap Inc., Apollo Hospitals Enterprise Ltd., Centinel Spine LLC, Premia Spine, Exactech Inc., Aesculap Inc., Lumitex LLC, Life Spine Inc., and Integra LifeSciences
Japan Stem Cell/Cord Blood Banking Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stem Cell/ Cord Blood Banking is expanding as a result of increase in healthcare and growing awareness among people. This demand is fueling the development of market for Stem Cell/Cord Blood Banking. Some of the key players in the global Stem Cell/Cord Blood Banking Market include CBR Systems, Inc., Cordlife, Cryo-Cell International, Inc., ViaCord, Cryo-Save, LifeCell International Pvt. Ltd., StemCyte India Therapeutics Pvt. Ltd., Global Cord Blood Corporation, Smart Cells International Limited, and Vita 34 International.
Japan Stroke Management and Care Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stroke Management and Care is growing as a result of rising prevalence of cardiovascular diseases, growing geriatric population, and advancements in technology. This demand is fueling the development of better care and management for stroke. Some of the key players in the global Stroke Management and Care Market include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Merck & Co., GE Healthcare, Siemens AG, Cardinal Health Inc., GlaxoSmithKline Plc, and Medtronic Plc.
Japan Synthetic Biology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Synthetic Biology is expanding as a result of rising demand for advancement in gene editing technology and genetic engineering in both developed and developing nations. This demand is fueling the development of better devices and methods for synthetic biology. Some of the key players in the global synthetic biology Market include Bota Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs; Euro fins Scientific; Novozymes; Pareto Bio, Inc.; Scarab Genomics, LLC; Synthego; Synthetic Genomics Inc.; and Thermo Fisher Scientific, Inc.
Japan Thrombocytopenia Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Thrombocytopenia is expanding as a result of increasing prevalence of thrombocytopenia and development of new treatment options. This demand is fueling the development of better devices and methods for the early and accurate diagnosis and treatment of Thrombocytopenia. Some of the key players in the global Thrombocytopenia Market include Sanofi, Principia Biopharma, Baxalta, Takeda, Argenx, Millennium Pharmaceuticals, Biotest, GC Pharma, Genosco (Subsidiary of Oscotec), Rigel Pharmaceuticals, Kissei Pharmaceutical, Shionogi & Co., Ltd, Amgen, Novartis, and Zenyaku Kogyo.
Japan Ultrasonic Technology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ultrasonic Technology is expanding as a result of rising chronic diseases and innovations in healthcare. This demand is fueling the growth of ultrasonic technology for the early detection and accurate diagnosis of various disease. Some of the key players in the global Ultrasonic Technology Market include Advanced Sonics, LLC, Crest Ultrasonics Corp., DPR Ultrasonic Technologies, Emerson Electric Co. (Branson), International Ultrasonic Technologies, Mosca GmbH, MS Industries AG, Sonotronic Nagel GmbH, Telsonic AG, and Ultrasonic Technologies, Inc.
Japan Urgent Care Center Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Urgent Care Center is expanding as a result of favorable government policies and increasing prevalence of chronic diseases and accidents. This demand is fueling the development of better infrastructures and facilities for urgent care center. Some of the key players in the global Urgent Care center market include Concentra, Inc.; American Family Care; CityMD Urgent Care; MedExpress Urgent Care; NextCare Urgent Care; Tenet Health Urgent Care; FastMed Urgent Care; Ascension Health Urgent Care; WellNow Urgent Care; Sutter Health; Aurora Urgent Care; and Intuitive Health.
Japan DNA Sequencing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for DNA Sequencing is expanding as a result of advances in DNA Sequencing technology and increased applications in clinical diagnosis drug discovery. This is raising the demand for the market and is leading to increased investment in research & development for DNA Sequencing. Some of the key players in the global DNA Sequencing Market include Aglient Technologies, Illumina, Inc., Hoffmann-La Roche Ltd., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Macrogen, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Ltd., Myriad Genetic, and Pacific Biosciences.
Japan's diabetes therapeutics market is expected to grow from $8.94 Bn in 2022 to $19.45 Bn in 2030 with a CAGR of 10.2% for the forecasted year 2022-30. The rise in the ageing population and obesity among the Japanese population is responsible for the growth of the market. The Japan diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Eisai, Otsuka Holdings, and Roche are the major players in the Japanese diabetes therapeutics market.
Japan's Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics market is expected to grow from $230 Mn in 2022 to $519 Mn in 2030 with a CAGR of 10.70% for the year 2022-30. PNH has been on the rise in Japan over the past several years in terms of incidence and prevalence. As a result, there is now a considerable market opportunity for producers of PNH medicines. The market is segmented by therapy, diagnostic test, by distribution channel. Some key players in this market include Takeda Pharmaceutical, Astellas Pharma, Otsuka Pharmaceutical, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring and Bioverativ.
This report presents a strategic analysis of the Japan ePharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Japan ePharmacy Market, offering unmatched value, accuracy and expert insights.
Japan's Palliative care market is projected to grow from $813.03 Mn in 2022 to $1561.52 Mn by 2030, registering a CAGR of 8.5% during the forecast period of 2022-30. The main factors driving the growth would be the growing homecare industry, technological advancements, the ageing population, and government support. The market is segmented by service type and by the end user. Some of the major players include Aichi International Hospital, Anjo Koesei Hospital, Nikko Memorial Hospital, Fukuyama City Hospital, and Home Instead.
By 2030, it is anticipated that the Japan dermatology drugs market will reach a value of $2.5 Bn from $1.06 Bn in 2022, growing at a CAGR of 11.3% during 2022-2030. The market is primarily dominated by local players such as Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., and Shionogi & Co., Ltd. The market is driven by an ageing population, increasing awareness of skin diseases, and the launch of new and innovative drugs. The dermatology drug market in Japan is segmented by drug class, drug type, prescription mode, indication, route of administration, end user and distribution channel.
Japan's Dialysis Market is projected to grow from $7.223 Bn in 2022 to $12.411 Bn by 2030, registering a CAGR of 7% during the forecast period of 2022 – 2030. The Japanese government has implemented several policies and regulations to support the development of the dialysis market in the country, such as the Long-term Care Insurance (LTCI) system, which covers the cost of dialysis treatment for eligible individuals, and the Basic Act for Health Insurance, which includes regulations for the provision of dialysis services. Some key players in the Japan dialysis market include Fresenius Medical Care, Baxter International, Nipro Medical Corporation, Nikkiso, Kawasumi Laboratories, and DaVita.
Japan's Retail pharmacy market is projected to grow from $64.56 Bn in 2022 to $114.28 Bn by 2030, registering a CAGR of 7.4% during the forecast period of 2022-2030. The growing demand for convenience in healthcare is driving the retail pharmacy market as more people are looking for ways to easily access and manage their medications. The retail pharmacy market in Japan is highly competitive, with several large players dominating the market, including Matsumoto Kiyoshi Holdings Co., Ltd, Aeon Co., Ltd, and Lawson, Inc.
Japan's Telemedicine Market is projected to grow from $3.779 Bn in 2022 to $14.894 Bn by 2030, registering a CAGR of 18.70% during the forecast period of 2022-2030. Japan has one of the oldest populations in the world, which has led to a higher demand for healthcare services. Telemedicine offers a way to provide healthcare to elderly patients who may have difficulty traveling to a hospital or clinic. Some key players in the Japanese telemedicine market include NTT Data, NEC Corporation, Fujitsu Limited, Panasonic Corporation, and Toshiba Corporation. Other notable players include telemedicine companies such as M3 Inc, Sony Corporation, Hitachi, Ltd, and Olympus Corporation.
Japan's 3D Imaging market is projected to grow from $ 1.89 Bn in 2022 to $ 6.63 Bn by 2030, registering a CAGR of 17% during the forecast period of 2022-30. The market will be driven by rising demand for precise medical imaging technologies & an increase in chronic illnesses in the growing population. The market is segmented by product, application, end-user & by portability. Some major players include Toshiba Medical Systems Corporation, Hitachi Medical Corporation & Shimadzu Corporation.
The Japan ECG Equipment Market is expected to witness growth from $554 Mn in 2022 to $1010 Mn in 2030 with a CAGR of 7.80% for the forecasted year 2022-2030. There are a lot of elderly individuals in Japan who are at an increased risk of cardiovascular disease due to the country's rapidly ageing population. Japan now has a greater need for ECG equipment as a result of this demographic tendency. The market is segmented by product type and by the end user. Some key players in this market include Nihon Kohden, Fukuda Denshi, Roland dg, Johnson & Johnson, Philipps Healthcare, Medtronic and Dexcom.